Insiders · Profile

Agresta Samuel

Chief Medical Officer at Foghorn Therapeutics. Filing since 16 Aug 2023. CIK 0001748961

Company

Date

Role

Action

Amount

Of holding

16 Aug 2023

Chief Medical Officer

Sold at will

311,297

$2.57M

100%

1 decision on file.